Free Trial

Henry Schein (NASDAQ:HSIC) Stock Rating Lowered by Wall Street Zen

Henry Schein logo with Medical background

Key Points

  • Henry Schein has been downgraded by Wall Street Zen from a "buy" rating to a "hold" rating, alongside similar downgrades from Baird R W.
  • The company's recent quarterly earnings revealed an EPS of $1.10, missing analysts' estimates, while revenue was slightly above expectations at $3.24 billion.
  • Henry Schein has a consensus rating of "Hold" with an average target price of $76.67, indicating cautious sentiment among analysts.
  • Interested in Henry Schein? Here are five stocks we like better.

Wall Street Zen cut shares of Henry Schein (NASDAQ:HSIC - Free Report) from a buy rating to a hold rating in a research note published on Sunday.

A number of other brokerages have also recently weighed in on HSIC. Evercore ISI upgraded Henry Schein from an "in-line" rating to an "outperform" rating and set a $83.00 price target on the stock in a research report on Tuesday, August 26th. Stifel Nicolaus reiterated a "hold" rating and issued a $75.00 price target (down from $80.00) on shares of Henry Schein in a research report on Friday, July 25th. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday, July 14th. UBS Group decreased their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 6th. Finally, Baird R W cut shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. Five research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $76.67.

Read Our Latest Analysis on HSIC

Henry Schein Stock Performance

Shares of HSIC traded down $0.46 on Friday, reaching $69.09. 163,714 shares of the stock traded hands, compared to its average volume of 1,737,907. The firm has a market cap of $8.38 billion, a price-to-earnings ratio of 22.32, a P/E/G ratio of 2.22 and a beta of 0.86. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.41 and a quick ratio of 0.78. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The stock's 50-day moving average price is $69.44 and its 200-day moving average price is $69.53.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion during the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter last year, the company earned $1.23 earnings per share. The business's revenue was up 3.3% on a year-over-year basis. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities analysts forecast that Henry Schein will post 4.74 EPS for the current fiscal year.

Institutional Trading of Henry Schein

Several large investors have recently made changes to their positions in HSIC. Jane Street Group LLC grew its holdings in shares of Henry Schein by 18.2% during the fourth quarter. Jane Street Group LLC now owns 25,556 shares of the company's stock worth $1,768,000 after purchasing an additional 3,932 shares during the last quarter. BNP Paribas Financial Markets grew its holdings in shares of Henry Schein by 20.4% during the fourth quarter. BNP Paribas Financial Markets now owns 222,057 shares of the company's stock worth $15,366,000 after purchasing an additional 37,575 shares during the last quarter. Balyasny Asset Management L.P. bought a new stake in shares of Henry Schein during the fourth quarter worth $5,565,000. Baird Financial Group Inc. grew its holdings in shares of Henry Schein by 36.3% during the fourth quarter. Baird Financial Group Inc. now owns 5,438 shares of the company's stock worth $376,000 after purchasing an additional 1,447 shares during the last quarter. Finally, Deutsche Bank AG lifted its stake in shares of Henry Schein by 21.0% during the fourth quarter. Deutsche Bank AG now owns 647,022 shares of the company's stock valued at $44,774,000 after acquiring an additional 112,408 shares during the period. Institutional investors own 96.62% of the company's stock.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

See Also

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Should You Invest $1,000 in Henry Schein Right Now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.